日本語English简体中文 繁體中文

300122 Chongqing Zhifei Biological Products Co., Ltd.智飞生物Shenzhen Stock Exchange

0 posts

Chongqing Zhifei Biological Products Co., Ltd. (300122) at a glance

Code
300122
Company
Chongqing Zhifei Biological Products Co., Ltd.
Local name
智飞生物
Market
Shenzhen Stock Exchange
Share price
CN¥14.14 -0.53 (-3.61%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Chongqing Zhifei Biological Products Co., Ltd. (300122) Stock Price History

Chongqing Zhifei Biological Products Co., Ltd. closed at CN¥14.14 on Nov 20, 2026, +13.1% over 1 month, −32.5% over 1 year.

2026-10-21 変更届 关于变更签字注册会计师的公告2026-10-23 新薬・製品の承認 关于鼻喷重组呼吸道合胞病毒疫苗(黑猩猩腺病毒载体)获得临床试验…2026-10-27 四半期報告 2026年三季度报告 / 取締役会決議 第六届董事会第十四次会议决议公告 / 自社株買い 关于拟签署股票回购专项贷款合同的公告 / 自社株買い 关于取得金融机构股票回购专项贷款承诺函的公告 / 新薬・製品の承認 关于自主产品冻干人用狂犬病疫苗(人二倍体细胞)获得药品注册证书…2026-11-02 自社株買い 关于回购公司股份的进展公告2026-11-06 新薬・製品の承認 关于大流行流感病毒mRNA疫苗临床试验申请获得受理的公告2026-11-13 新薬・製品の承認 关于冻干人用狂犬病疫苗(ZFB-3细胞)获得临床试验批准通知书的公告2026-11-17 新薬・製品の承認 关于冻干重组呼吸道合胞病毒蛋白疫苗(CHO细胞)临床试验申请获得…2026-11-20 自社株買い 关于回购公司股份的进展公告CN¥14.94CN¥12.43Oct 20Nov 20
Price5-day MA25-day MASSE CompositeDisclosures
1-Month HighCN¥14.94Nov 5
1-Month LowCN¥12.43Oct 22
1-Week Change+2.1%vs Nov 13
1-Month Change+13.1%vs Oct 20

If you had invested CN¥10,000 1 month ago, it would be worth CN¥11,312 today (+13.1%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −5.4%, while this stock moved +13.1%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)CN¥14.14−0.53−3.61%
Nov 19 (Thu)CN¥14.67−0.19−1.28%
Nov 18 (Wed)CN¥14.86+1.32+9.75%
Nov 17 (Tue)CN¥13.54−0.07−0.51%
Nov 16 (Mon)CN¥13.61−0.24−1.73%
Nov 13 (Fri)CN¥13.85+0.00+0.00%
Nov 12 (Thu)CN¥13.85−0.20−1.42%
Nov 11 (Wed)CN¥14.05−0.37−2.57%
Nov 10 (Tue)CN¥14.42−0.11−0.76%
Nov 9 (Mon)CN¥14.53−0.38−2.55%
2026-09-18 決算説明会 关于参加重庆辖区上市公司2026年投资者网上集体接待日暨半年度业绩说明会…2026-10-09 自社株買い 关于回购公司股份的进展公告2026-10-16 自社株買い 关于首次回购公司股份暨回购股份进展的公告2026-10-21 変更届 关于变更签字注册会计师的公告2026-10-23 新薬・製品の承認 关于鼻喷重组呼吸道合胞病毒疫苗(黑猩猩腺病毒载体)获得临床试验…2026-10-27 四半期報告 2026年三季度报告 / 取締役会決議 第六届董事会第十四次会议决议公告 / 自社株買い 关于拟签署股票回购专项贷款合同的公告 / 自社株買い 关于取得金融机构股票回购专项贷款承诺函的公告 / 新薬・製品の承認 关于自主产品冻干人用狂犬病疫苗(人二倍体细胞)获得药品注册证书…2026-11-02 自社株買い 关于回购公司股份的进展公告2026-11-06 新薬・製品の承認 关于大流行流感病毒mRNA疫苗临床试验申请获得受理的公告2026-11-13 新薬・製品の承認 关于冻干人用狂犬病疫苗(ZFB-3细胞)获得临床试验批准通知书的公告2026-11-17 新薬・製品の承認 关于冻干重组呼吸道合胞病毒蛋白疫苗(CHO细胞)临床试验申请获得…2026-11-20 自社株買い 关于回购公司股份的进展公告CN¥15.00CN¥12.21Aug 20Nov 20
Price5-day MA25-day MASSE CompositeDisclosures
3-Month HighCN¥15.00Aug 27
3-Month LowCN¥12.21Sep 15
1-Month Change+13.1%vs Oct 20
3-Month Change−2.3%vs Aug 20

If you had invested CN¥10,000 3 months ago, it would be worth CN¥9,765 today (−2.3%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −9.5%, while this stock moved −2.3%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)CN¥14.14−0.53−3.61%
Nov 19 (Thu)CN¥14.67−0.19−1.28%
Nov 18 (Wed)CN¥14.86+1.32+9.75%
Nov 17 (Tue)CN¥13.54−0.07−0.51%
Nov 16 (Mon)CN¥13.61−0.24−1.73%
Nov 13 (Fri)CN¥13.85+0.00+0.00%
Nov 12 (Thu)CN¥13.85−0.20−1.42%
Nov 11 (Wed)CN¥14.05−0.37−2.57%
Nov 10 (Tue)CN¥14.42−0.11−0.76%
Nov 9 (Mon)CN¥14.53−0.38−2.55%
2026-09-18 決算説明会 关于参加重庆辖区上市公司2026年投资者网上集体接待日暨半年度业绩说明会…2026-10-09 自社株買い 关于回购公司股份的进展公告2026-10-16 自社株買い 关于首次回购公司股份暨回购股份进展的公告2026-10-21 変更届 关于变更签字注册会计师的公告2026-10-23 新薬・製品の承認 关于鼻喷重组呼吸道合胞病毒疫苗(黑猩猩腺病毒载体)获得临床试验…2026-10-27 四半期報告 2026年三季度报告 / 取締役会決議 第六届董事会第十四次会议决议公告 / 自社株買い 关于拟签署股票回购专项贷款合同的公告 / 自社株買い 关于取得金融机构股票回购专项贷款承诺函的公告 / 新薬・製品の承認 关于自主产品冻干人用狂犬病疫苗(人二倍体细胞)获得药品注册证书…2026-11-02 自社株買い 关于回购公司股份的进展公告2026-11-06 新薬・製品の承認 关于大流行流感病毒mRNA疫苗临床试验申请获得受理的公告2026-11-13 新薬・製品の承認 关于冻干人用狂犬病疫苗(ZFB-3细胞)获得临床试验批准通知书的公告2026-11-17 新薬・製品の承認 关于冻干重组呼吸道合胞病毒蛋白疫苗(CHO细胞)临床试验申请获得…2026-11-20 自社株買い 关于回购公司股份的进展公告CN¥15.00CN¥11.37May 20Nov 20
Price25-day MA75-day MASSE CompositeDisclosures
6-Month HighCN¥15.00Aug 27
6-Month LowCN¥11.37Jul 9
3-Month Change−2.3%vs Aug 20
6-Month Change−4.1%vs May 20

If you had invested CN¥10,000 6 months ago, it would be worth CN¥9,593 today (−4.1%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −15.1%, while this stock moved −4.1%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026CN¥14.14+4.8%
Oct 2026CN¥13.49−3.5%
Sep 2026CN¥13.98+2.3%
Aug 2026CN¥13.66+4.8%
Jul 2026CN¥13.04+11.5%
Jun 2026CN¥11.69−14.0%
May 2026CN¥13.59−10.3%
2026-09-18 決算説明会 关于参加重庆辖区上市公司2026年投资者网上集体接待日暨半年度业绩说明会…2026-10-09 自社株買い 关于回购公司股份的进展公告2026-10-16 自社株買い 关于首次回购公司股份暨回购股份进展的公告2026-10-21 変更届 关于变更签字注册会计师的公告2026-10-23 新薬・製品の承認 关于鼻喷重组呼吸道合胞病毒疫苗(黑猩猩腺病毒载体)获得临床试验…2026-10-27 四半期報告 2026年三季度报告 / 取締役会決議 第六届董事会第十四次会议决议公告 / 自社株買い 关于拟签署股票回购专项贷款合同的公告 / 自社株買い 关于取得金融机构股票回购专项贷款承诺函的公告 / 新薬・製品の承認 关于自主产品冻干人用狂犬病疫苗(人二倍体细胞)获得药品注册证书…2026-11-02 自社株買い 关于回购公司股份的进展公告2026-11-06 新薬・製品の承認 关于大流行流感病毒mRNA疫苗临床试验申请获得受理的公告2026-11-13 新薬・製品の承認 关于冻干人用狂犬病疫苗(ZFB-3细胞)获得临床试验批准通知书的公告2026-11-17 新薬・製品の承認 关于冻干重组呼吸道合胞病毒蛋白疫苗(CHO细胞)临床试验申请获得…2026-11-20 自社株買い 关于回购公司股份的进展公告CN¥20.94CN¥11.37Nov 20Nov 20
Price25-day MA75-day MASSE CompositeDisclosures
52-Week HighCN¥20.94Nov 20
52-Week LowCN¥11.37Jul 9
Year to Date−25.1%vs Dec 31
From 52-Week High−32.5%Nov 20

If you had invested CN¥10,000 1 year ago, it would be worth CN¥6,753 today (−32.5%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −10.1%, while this stock moved −32.5%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026CN¥14.14+4.8%
Oct 2026CN¥13.49−3.5%
Sep 2026CN¥13.98+2.3%
Aug 2026CN¥13.66+4.8%
Jul 2026CN¥13.04+11.5%
Jun 2026CN¥11.69−14.0%
May 2026CN¥13.59−10.3%
Apr 2026CN¥15.15+1.3%
Mar 2026CN¥14.96−13.5%
Feb 2026CN¥17.29−0.5%
Jan 2026CN¥17.37−7.9%
Dec 2025CN¥18.87−8.2%
Nov 2025CN¥20.56―
CN¥66.12CN¥11.38Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MASSE Composite
3-Year HighCN¥66.12Nov 20, 2023
3-Year LowCN¥11.38Jun 26, 2026
Annualized Return−40.2%
Max Drawdown−82.8%

If you had invested CN¥10,000 3 years ago, it would be worth CN¥2,139 today (−78.6%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +16.2%, while this stock moved −78.6%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥14.14−25.1%
2025CN¥18.87―
CN¥90.62CN¥11.38Nov 22, 2021Nov 20, 2026
Price13-week MA26-week MASSE Composite
5-Year HighCN¥90.62Mar 14, 2022
5-Year LowCN¥11.38Jun 26, 2026
Annualized Return−30.0%
Max Drawdown−87.4%

If you had invested CN¥10,000 5 years ago, it would be worth CN¥1,690 today (−83.1%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −0.9%, while this stock moved −83.1%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥14.14−25.1%
2025CN¥18.87―
CN¥146.40CN¥3.40Oct 1, 2010Nov 20, 2026
Price1-year MA2-year MASSE Composite
All-Time HighCN¥146.40Apr 2021
All-Time LowCN¥3.40Jan 2012
Total Change+112.5%vs Oct 2010
Annualized Return+4.8%

If you had invested CN¥10,000 in Oct 2010, it would be worth CN¥21,250 today (+112.5%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +18.6%, while this stock moved +112.5%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥14.14−25.1%
2025CN¥18.87−28.3%
2024CN¥26.30−57.0%
2023CN¥61.11+7.2%
2022CN¥57.03−29.5%
2021CN¥80.91−15.8%
2020CN¥96.05+197.8%
2019CN¥32.25+28.1%
2018CN¥25.17+38.1%
2017CN¥18.23+70.4%
2016CN¥10.70−9.5%
2015CN¥11.81+82.6%
2014CN¥6.47−17.0%
2013CN¥7.79+44.6%
2012CN¥5.39+22.6%
2011CN¥4.40−23.7%
2010CN¥5.76―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Oct 2010). Please check the latest prices before trading.

Key features of Chongqing Zhifei Biological Products Co., Ltd. (300122)

Position within Biological Products (57 companies)

PBR2.23xEqual to the industry median of 2.23x (No. 28 from the lowest)
ROE-62.67%No. 54 in the industry (highest first); median 2.38%
Market capCN¥33.8 bnNo. 4 in the industry (largest first)

Ranks among A-shares in the same industry (Eastmoney's Shenwan level-2 classification, 128 industries). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest. ROE is from the latest annual results; dividend yield is the past year's dividends divided by the close (as of 11/20).

Price milestones

52-week highCN¥20.562025/12/1
52-week lowCN¥11.377/9
Current position30.1%Where the low is 0% and the high is 100% (close on 11/20: CN¥14.14)
Year to date-25.1%No. 23 of 56 in the industry (best first)
1 year-32.5%

Based on closing prices (excluding dividends).

Kabutaro's ranking history

Top 50 gainers2 timesLatest: 8/20 (No. 21 among A-shares)

Gainers and losers are counted day by day from closing prices over the past year (ranked within A-shares and Hong Kong stocks separately). For A-shares, moves beyond the daily price limit (stock splits, first days after listing, etc.) are excluded.

Calculated as of 2026/11/22 18:32 JST. Updated every evening.

Recent announcements (CNINFO, in Chinese)

Show 6 more

Filings from the past 12 months (16).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the Chongqing Zhifei Biological Products Co., Ltd. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Chinese stocks in English

Chinese Stock Message Board: stocks available in English

Other boards in English